:format(jpg):quality(99):watermark(f.elconfidencial.com/file/6fe/9f8/aff/6fe9f8affe583116fd468a903c287c44.png,0,275,1)/f.elconfidencial.com/original/a09/986/70a/a0998670a6bb5712a52b088a61216fa6.jpg "This is the new test that detects persistent covid with 90% accuracy.")
At least 17 million people in the 53 member states of the WHO European Region suffered from “persistent covid in the first two years of the pandemic”, as revealed by a research by the School of Medicine of the University of Washington, presented this Monday at the 72nd session of the WHO European Regional Committee.
In Spain it is estimated that between 10 and 15% of the population who suffered from covid-19 continued with symptoms weeks after infection, reaching figures that exceed the million Spaniards who has suffered or suffers from persistent covid.
To detect this continued effect of covid, which can manifest itself with more than 200 symptoms, a new analysis has just arrived in Spain. Doctors in our country can now use an authorized test in Europe which is thought to be useful for detecting prolonged covid and which is carried out through A blood test.
:format(jpg)/f.elconfidencial.com%2Foriginal%2F899%2F9d5%2F6b2%2F8999d56b222a4bea05ebb1df7aebc195.jpg)
They identify the over 200 symptoms of persistent covid
Fran Sanchez Becerril
Called IncellKINE Long Covid in Vitro Diagnostic, it is made up of a study for cytometry flow rate of a specific combination of inflammatory markers (cyto and chemokine), as explained in a press release from the Synlab laboratory.
immunological analysis detects specific immune signatures of persistent covidwith an accuracy in identifying this immune signature greater than 90%, according to validation studies.
Use of artificial intelligence
The results are then processed using artificial intelligence tools which would make it possible to identify those patients suffering from prolonged covid, a disease that is estimated to affect between 10 and 15 percent of patients who have suffered from coronavirus to varying degrees.
File photo: EFE/Jesús Diges.
Synlab, associated with IncellDx, will bring this test to Spain which they consider “an innovative tool”. With this, the doctors who care for these patients will be able to improve the possibility of segmenting them and will act as a more effective help compared to existing ones for clinical and therapeutic management.
At least 17 million people in the 53 member states of the WHO European Region suffered from “persistent covid in the first two years of the pandemic”, according to research by the School of Medicine of the University of Washington, presented this Monday at the 72nd session of the WHO European Regional Committee.
